MU opioid receptor ligands: agonists and antagonists

Details MU opioid receptor ligands: agonists and antagonists MU opioid receptor ligands: agonists and antagonists

1995-06-07

1999-07-06

Tsang, Cecilia J.

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

4 to 5 amino acid residues in defined sequence

530331, 530345, 514 18, 514 19, 2609982, C07K 500

Patent

active

059198974

ABSTRACT:
The present invention provides novel opioid peptides. Disclosed are opioid peptides having the general structures Ac-Phe-Arg-Trp-Trp-Tyr-Xaa-NH.sub.2 (SEQ ID NO. 1); Ac-Arg-Trp-Ile-Gly-Trp-Xaa-NH.sub.2 (SEQ ID NO. 2); Trp-Trp-Pro-Lys-His-Xaa-NH.sub.2 (SEQ ID NO. 3); and shorter versions of the latter, namely, Trp-Trp-Pro-Xaa-NH.sub.2 (SEQ ID NO. 4); Tyr-Pro-Phe-Gly-Phe-Xaa-NH.sub.2 (SEQ ID NO. 5); (D)Ile-(D)Met-(D)Ser-(D)Trp-(D)Trp-Gly.sub.n -Xaa-NH.sub.2 (SEQ ID NO. 6); and (D)Ile-(D)Met-(D)Thr-(D)Trp-Gly-Xaa-NH.sub.2 (SEQ ID NO. 7). Within each genus, Xaa is substituted by a specific amino acid. The invention also relates to an opioid peptide having the general structure Tyr-A1-B2-C3-NH.sub.2 (SEQ ID NO. 214), wherein A is D-Nve or D-Nle, B is Gly, Phe, or Trp, and C is Trp or Nap. Also included within the invention are opioid peptides of the general structure Me.sub.x H.sub.y N-Tyr-Tyr-Phe.sub.m -Pro.sub.n -NH.sub.2 (SEQ ID NO. 221) which are peptides modified by permethylation, perallylation, perethylation, perbenzylation and/or pernaphthylation and which can be further modified by reduction.

REFERENCES:
patent: 5367053 (1994-11-01), Dooley et al.
patent: 5455230 (1995-10-01), Schiller
patent: 5480971 (1996-01-01), Houghten et al.
Charpentier et al., Biochem. Biophys. Res. Commun 179 (3), 1161-8. Abstract, 1991.
STN International Fast Notes.
Dooley et al., "Acetalins: Opioid receptor antagonists determined through the use of synthetic peptide combinatorial libraries." Proc. Natl. Acad. Sci. USA, 90:10811-10815 (1993).
Dooley et al., "An all D-Amino acid opioid peptide with central analgesic activity from a combinatorial library." Science, 266:2019-2022, 1994.
Dooley et al., "Rapid identification of novel opioid peptides from an N-acetylated synthetic combinatorial library," Regulatory Peptides,54:87-88 (1994).
Ostresh et al., "Libraries from libraries: Chemical transformation of combinatorial libraries to extend he range and repertoire of chemical diversity." Proc. Natl. Acad. Sci. USA, 91:11138-11142 (1994).
Dooley and Houghten, "The use of positional scanning synthetic peptide combinatorial libraries for the rapid determination of opioid receptor ligands," Life Science, 52:1509-1517 (1993).
Erchegyi et al., Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH.sub.2 (Tyr-W-MIF-1) Peptides, 13:623-631 (1992).
Schiller et al., "Unsulfated C-terminal 7-peptide of cholecystokinin: a new ligand of the opiate receptor." Biochem. and Biophys. Res. Comm., 85(4) :1332-1338 (1978).
Blondelle et al., "Soluble combinatorial libraries of organic, peptidomimetic and peptide diversities." Trends in Analytical Chem., 14(2) :83-92 (1995).
Schiller Peter W., "Development of receptor-specific opioid peptide analogues." Progress in Medicinal Chem., 28:301-340 (1991).
Dooley et al., "Identification of tetrameric opioid peptides from a combinatorial library composed of L-, D-and non-proteinogenic amino acids." In H.L.S. Maia (Ed), Peptides 94: Proceedings of the 23rd European Peptide Symposium. Escom, Leides (1995).
Houghten and Dooley, "The use of synthetic peptide combinatorial libraries for the determination of peptide ligands in radio-receptor assays: opioid peptides." BioMed. Chem Lett., 3:405-412 (1993).
Hruby and Gehrig, "Recent developments in the design of receptor specific opioid peptides." Medicinal Res. Rev., 9(3):343-401 (1989).

Affiliated with

Also associated with

Rating

MU opioid receptor ligands: agonists and antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with MU opioid receptor ligands: agonists and antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MU opioid receptor ligands: agonists and antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-899890